StonvexLoading…
StonvexCore line items from PRE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 |
|---|---|---|---|---|
Revenue | $21.74M | $13.16M | $12.53M | $65.18M |
Operating Income | $-51.91M | $-66.02M | $-56.66M | $-995.13K |
Net Income | $-64.78M | $-190.45M | $-174.02M | $-1.96M |
EPS (Diluted) | $-5.58 | $-37.57 | $-178.81 | $-0.15 |
Total Assets | $254.17M | $312.13M | $148.51M | Not available |
Total Liabilities | $44.01M | $68.67M | $549.40M | Not available |
Cash & Equivalents | $45.71M | $146.66M | $35.29M | $14.49M |
Free Cash Flow OCF − CapEx | $-14.11M | $9.57M | $4.87M | $-5.74M |
Shares Outstanding | 12.21M | Not available | Not available | Not available |